Skip to content

Role of Homoeopathic medicine in treatment of Piles

Role of Repetition of Doses using Centesimal Potency in managing 1st and 2nd degree Hemorrhoids in 35-65 age - Assessed by HDSS - Prospective Experimental Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097561
Enrollment
30
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

Intervention1: Individualized Homoeopathic Medicine in Centesimal Potency: Selection of potency will be done as per the guidelines given by Dr Hahnemann. Repetitions of doses will be done as per this

Sponsors

Dr Jinal Mevada
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with 1st and 2nd degree Hemorrhoids diagnosed according to ICD-11 Patients who are suffering from 1st and 2nd degree hemorrhoids for more than 3 months Participants willing to provide informed consent to participate in the study Participants who can fill out the assessment score by themselves

Exclusion criteria

Exclusion criteria: Patients having fissure in Ano fistula in Ano malignancy Crohns disease ulcerative colitis and other diseases with rectal complaints Patients on treatment with anticoagulants Pregnant and lactating women Patients who are on allopathic ayurvedic homoeopathic or any other mode of treatment will be included after a washout period of 7 days

Design outcomes

Primary

MeasureTime frame
Change in the Hemorrhoidal Diseases Symptom scoreTimepoint: Change in the Hemorrhoidal Diseases Symptom score will be assessed at the baseline and at the end of the treatment

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Jinalben Kamleshbhai Mevada

Smt A J Savla Homoeopathic Medical College and Research Institute Mahesana

dranandjvb@gmail.com9429545666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026